跳至主要内容
临床试验/NCT04819958
NCT04819958Unknown不适用

The Effect of Immunological Heterogeneity of Tumor Microenvironment in the Short-term Outcome and Long-term Outcome of Patients With Gastric Cancer

Fujian Medical University1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2021年3月31日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
20
试验地点
1
主要终点
3-year disease free survival rate

研究概览

简要总结

The purpose of this study is to explore the effect of immunological heterogeneity of tumor microenvironment in the short-term outcome and long-term outcome of patients with gastric cancer.

详细描述

A prospective cohort study will be performed to explore the effect of immunological heterogeneity of tumor microenvironment in the short-term outcome and long-term outcome of patients with gastric cancer. The evaluation parameters are perioperative clinical efficacy, postoperative complications, and 3-year survival and recurrence rates.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age from 18 to 80 years
  • Histology confirmed gastric adenocarcinoma (papillary, tubular, mucinous, signet ring cell, or poorly differentiated) confirmed pathologically by endoscopic biopsy.
  • Clinical stage: cTNM: stage I or above at preoperative evaluation according to the American Joint Committee on Cancer (AJCC) Cancer Staging Manual Eighth Edition
  • Performance status: Eastern Cooperative Oncology Group (ECOG) ≤ 2 (normal to symptomatic but in bed less than half the day)
  • Clinically fit for gastric cancer surgery, i.e. adequate renal, hepatic, hematologic, and pulmonary function.
  • Written informed consent

排除标准

  • Women during pregnancy or breast-feeding
  • Severe mental disorder
  • History of previous gastrectomy, endoscopic mucosal resection, or endoscopic submucosal dissection
  • History of other malignant diseases within the past five years
  • History of unstable angina or myocardial infarction within the past six months
  • History of a cerebrovascular accident within the past six months
  • History of continuous systematic administration of corticosteroids within one month
  • Requirement of simultaneous surgery for other diseases
  • Emergency surgery due to complication (bleeding, obstruction, or perforation) caused by gastric cancer
  • Forced expiratory volume in 1 second (FEV1)<50% of predicted values
  • Inclusion in another clinical trial

结局指标

主要结局

3-year disease free survival rate

时间窗: 36 months

3-year disease free survival rate

次要结局

  • The variation of C-reactive protein(Preoperative 7 days and postoperative 1, 3, and 5 days)
  • 3-year recurrence pattern(36 months)
  • 3-year overall survival rate(36 months)
  • Time to first flatus(30 days)
  • Total number of retrieved lymph nodes(One month after surgery)
  • Intraoperative morbidity rates(1 day)
  • The variation of white blood cell count(Preoperative 7 days and postoperative 1, 3, and 5 days)
  • Time to first ambulation(30 days)
  • Time to first soft diet(30 days)
  • Morbidity rates(30 days)
  • Mortality rates(30 days)
  • The variation of hemoglobin(Preoperative 7 days and postoperative 1, 3, and 5 days)
  • Time to first liquid diet(30 days)
  • Duration of postoperative hospital stay(30 days)

研究者

发起方
Fujian Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Chang-Ming Huang, Prof.

Director, Head of Department of Gastric Surgery, Principal Investigator, Clinical Professor

Fujian Medical University

研究点 (1)

Loading locations...

相似试验

The Effect of Immunological Heterogeneity of Tumor... | 临床试验